Klotho Neurosciences, INC. (GRMLW) — 10-Q Filings
All 10-Q filings from Klotho Neurosciences, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Klotho Neurosciences' Net Loss Widens to $9.2M Amid Soaring Expenses
— Nov 13, 2025 Risk: high
Klotho Neurosciences, Inc. (GRMLW) reported a net loss of $9,222,798 for the nine months ended September 30, 2025, a significant increase from the $4,083,109 ne -
Klotho Neurosciences Files Q2 2025 10-Q
— Aug 18, 2025 Risk: low
Klotho Neurosciences, Inc. filed its quarterly report for the period ending June 30, 2025. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquis -
Klotho Neurosciences Files Q1 2025 10-Q
— May 15, 2025 Risk: low
Klotho Neurosciences, Inc. filed its quarterly report for the period ended March 31, 2025. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquis -
Klotho Neurosciences Files Q3 2024 10-Q
— Nov 19, 2024 Risk: medium
Klotho Neurosciences, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, formerly known as ANEW Medical, Inc. an -
ANEW Medical Files Q2 2024 10-Q Report
— Aug 19, 2024 Risk: low
ANEW Medical, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, formerly known as Redwoods Acquisition Corp. until J -
Redwoods Acquisition Corp. Files 10-Q for Q1 2024
— May 23, 2024 Risk: low
Redwoods Acquisition Corp. filed its 10-Q for the quarterly period ended March 31, 2024. The company, incorporated in Delaware, operates in the Biological Produ
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX